Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

C92B4E06C2964B0087258241007323BE Hearing Summary




PUBLIC
BILL SUMMARY For UPDATE FROM THE OPIOID AND OTHER SUBSTANCE USE DISORDERS INTERIM STUDY COMMITTEE

HOUSE COMMITTEE ON PUBLIC HEALTH CARE & HUMAN SERVICES
Date Feb 27, 2018      
Location RM 271



Update from the Opioid and Other Substance Use Disorders Interim Study Committee - Committee Discussion Only


01:57:40 PM  

Representative Pettersen provided an overview on the work of the Opioid and Other Substance Use Disorders Interim Committee over the interim.

01:58:38 PM  

A handout was distributed to the committee (Attachment A).  Dr. Robert Valuck, Consortium for Prescription Drug Abuse Prevention, provided statistics on opioid overdose deaths nationally and in Colorado.  

02:05:23 PM  

Dr. Valuck described the costs of the opioid epidemic on the economy.  He explained the treatment gap for substance abuse and the reasons treatment is not sought.    

02:09:43 PM  
Dr. Valuck responded to questions regarding
overdose deaths, data on opioid prescriptions, and illegal drug trafficking.
 
02:17:01 PM  

Dr. Valuck explained how prescribed opioids became prevalent in the U.S.  Representative Pettersen and Dr. Valuck responded to committee questions on opioid prescribing rates under Medicaid.

02:24:16 PM  
Dr. Valuck described recent efforts to
combat opioid abuse including the President's Commission, new federal funding
for treatment expansion, and progress with Colorado's Plan to Reduce Prescription
Drug Abuse.  
02:39:36 PM  
Dr. Valuck responded to committee questions regarding harm reduction strategies.
02:40:36 PM  

Jose Esquibel, Colorado Office of the Attorney General, discussed Colorado's response to substance abuse through the Substance Abuse Trend and Response Task Force.

02:49:55 PM  
Representative Pettersen commented on effective substance use treatment and transitioning from prescription drugs to illegal drugs.
02:52:38 PM  

Mr. Esquibel summarized six areas of legislative focus regarding the opioid epidemic in Colorado.

03:00:44 PM  

Dr. Valuck responded to committee questions regarding costs of proposed legislation and different treatment options.  

03:03:06 PM  

Theresa Manocchio anbd Emily Johnson, Colorado Health Institute, presented on a feasibility study regarding House Bill 17-1351.  Ms. Manocchio discussed the fiscal impacts of House Bill 17-1351.

03:29:13 PM  
Ms. Johnson responded to committee questions.






Colorado legislature email addresses ending in @state.co.us are no longer active. Please replace @state.co.us with @coleg.gov for Colorado legislature email addresses.  Details